Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FHGV5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,688
Award facts
- Contract value 100% obligated
- $31,687.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $31,687.68 for BOTOX 200 Unit Vials on December 22, 2025, with an ultimate completion date of January 14, 2026. The Defense Logistics Agency issued this firm fixed-price delivery order without a set-aside designation, reflecting the company's competitive capability in unrestricted federal procurement. This award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR and valued at $499,999,999 through December 31, 2036.
The PPV-G GEN V represents part of the Defense Logistics Agency's broader $30.3 billion pharmaceutical acquisition strategy to supply branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has demonstrated substantial federal contracting activity through numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division, with its product portfolio encompassing oncology treatments, immunosuppressants, vaccines, emergency medications, and specialty pharmaceuticals. This delivery order for BOTOX 200 Unit Vials supports the recurring medical supply needs of military healthcare operations and reflects the company's established performance as a critical pharmaceutical supplier within the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FHGV5?
SPE2DR26FHGV5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FHGV5 worth?
The government has obligated $31,688 on SPE2DR26FHGV5.
Is contract SPE2DR26FHGV5 an order under another contract?
Yes. SPE2DR26FHGV5 is a delivery order under SPE2DR25D9244, an indefinite delivery contract.
Was contract SPE2DR26FHGV5 competed?
The extent of competition for SPE2DR26FHGV5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award